DBT Bureau
Bengaluru, 8 January
BrainSight AI, a Bengaluru-based deep-tech neuroscience startup, has raised Pre-series A funding with US$5 million led by IAN Alpha Fund, with participation from IvyCap Ventures, Silver Needle, apart from existing investors.
The funding is a significant milestone in BrainSightAI’s mission to revolutionize the diagnosis and treatment of complex brain disorders through its innovative neuroinformatics platform, VoxelBox, the company said in a press release.
Currently, BrainSightAI collaborates with over 40 leading hospitals across India, particularly in neurosurgery and radiology departments, focusing on brain tumor cases. The company is now expanding its solutions to neurological and psychiatric disorders, paving the way for a more holistic approach to brain care.
The funds from this round will be utilized to expand BrainSightAI’s presence in India, increasing its reach in tier 1 cities and extend to tier 2 cities. The company also plans to pursue FDA certification, opening access to the US and allied markets. Additionally, the company is gearing up to explore opportunities in Africa and Southeast Asia, based on distributor interest. The funds will also support R&D for a caregiver-focused app, aimed at empowering families of patients with brain disorders.
